DataPile investor atlas
Angel investors & venture capitalists in Indiana, United States
Last updated 25-10-2025. Data refreshed weekly.
3
Matches for your filters
16
Total investors in region
3,050
Profiles tracked nationwide
16
Based in Indiana
Indianapolis (6)
Largest investor hub
Eli Lilly and Company, Samtec Inc
Notable firms
Refine investor results
Toggle multiple filters to narrow the directory instantly.
Location
States & regions
Cities
Industry focus
We found 3 investors matching "Eli Lilly and Company".
Market intelligence
- Most active investment themes in Indiana, United States: venture capital & private equity, electrical, electronic manufacturing.
- 6 profiles are headquartered in Indianapolis, making it the busiest hub in Indiana, United States.
- Featured firms include Eli Lilly and Company, Samtec Inc, Miles Ahead, American Water.
Explore states in United States
California
797
New York
628
Massachusetts
200
Texas
180
Florida
128
Illinois
95
Pennsylvania
87
Washington
70
Colorado
56
Ohio
49
Michigan
47
North Carolina
46
District of Columbia
45
Georgia
43
Maryland
42
Tennessee
36
Virginia
36
New Jersey
27
Minnesota
27
Utah
25
Connecticut
24
Arizona
24
Nevada
19
Missouri
18
Oregon
18
Indiana
16
Wisconsin
13
South Carolina
12
Arkansas
9
New Hampshire
8
Kentucky
8
Nebraska
7
Louisiana
6
Rhode Island
5
Oklahoma
5
Hawaii
4
Alabama
4
Idaho
3
Wyoming
3
Iowa
3
Vermont
3
Kansas
3
Montana
2
Maine
2
Delaware
2
New Mexico
1
Mississippi
1
Alaska
1
Investor hotspots
Frequently mentioned firms
Showing 1 – 3 of 3 investors
Eli Lilly and Company
- Focus areas
-
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
- Location
- Indianapolis, Indiana, United States
Eli Lilly and Company
- Focus areas
-
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
- Location
- Indianapolis, Indiana, United States
Eli Lilly and Company
- Focus areas
-
pharmaceuticals pharmaceutical development pharmaceuticals biotech biopharmaceuticals biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing biotech research in gene therapy biotech research in personalized medicine medical devices biotech research in neurodegenerative diseases biopharmaceutical research global markets medical advancements biotech acquisitions biotech research in oncology biotech research in infectious diseases research facilities medical research biotech research in autoimmune diseases research and development scientific research medicines development biotech research sustainability services healthcare innovation biotech research in rare diseases biotech research in precision medicine drug safety clinical research pipeline biotech research in chronic diseases biotech research in cancer drug pipeline corporate governance therapeutic innovation biotech research in biologics healthcare services biotech research in biosimilars regulatory standards biotech research in neuroinflammation clinical research management product development product portfolio research collaborations neuroscience biotech research in immunology healthcare therapeutic treatments biopharmaceutical innovation medical science pharmaceutical and medicine manufacturing therapeutic areas medical innovation biotech research in autoimmune disorders healthcare solutions biotech innovation drug discovery clinical development oncology scientific discovery market expansion biotech research in inflammatory diseases regulatory compliance biotech research in metabolic syndromes biotech research in molecular diagnostics patient care biotech research in regenerative medicine biopharmaceutical pipeline clinical research in immunology biotech research in genetic disorders biotech research in metabolic diseases pharmaceutical innovation innovative medicines global healthcare insulin biotech research in vaccine development clinical research biotech companies immunology healthcare products biotechnology acquisitions biotech research in neuroscience biotech research collaborations medical treatments drug development biotech research in cardiovascular diseases community impact healthcare technology insulin production drug efficacy healthcare providers b2b biotech innovation in diabetes biotech partnerships patient-centered care oncology treatments pharmaceutical company medical breakthroughs pharmaceutical clinical trials drug manufacturing biotech research in rare cancers drug approval process medicine pharmaceutical research cancer treatments diabetes medications alzheimer's research immunology solutions patient safety diversity in clinical trials clinical development pipeline medication safety chronic disease management insulin affordability patient assistance programs oncology support health equity environmental impact corporate social responsibility customized treatment solutions neurodegenerative diseases clinical research partnerships clinical data management quality assurance in pharmaceuticals health outcomes community engagement affordable healthcare sustainability initiatives patient stories lilly foundation healthcare access patient-centric approach global health diversity and inclusion health and wellness programs lilly cares foundation ongoing medical education medication adherence programs genetic medicine research manufacturing distribution drug_development clinical_trials medical_research research_facilities regulatory_compliance corporate_governance community_impact global_markets innovative_medicines product_portfolio patient_care scientific_discovery medical health wellness & fitness hospital & health care research & development environmental services renewables & environment mechanical or industrial engineering
- Location
- Indianapolis, Indiana, United States
No investors match the selected filters. Try broadening your criteria or exploring neighbouring ecosystems.
Explore other regions in United States
- California (797)
- New York (628)
- Massachusetts (200)
- Texas (180)
- Florida (128)
- Illinois (95)
- Pennsylvania (87)
- Washington (70)
- Colorado (56)
- Ohio (49)
- Michigan (47)
- North Carolina (46)
- District of Columbia (45)
- Georgia (43)
- Maryland (42)
- Tennessee (36)
- Virginia (36)
- New Jersey (27)
- Minnesota (27)
- Utah (25)
- Connecticut (24)
- Arizona (24)
- Nevada (19)
- Missouri (18)
- Oregon (18)
- Indiana (16)
- Wisconsin (13)
- South Carolina (12)
- Arkansas (9)
- New Hampshire (8)
- Kentucky (8)
- Nebraska (7)
- Louisiana (6)
- Rhode Island (5)
- Oklahoma (5)
- Hawaii (4)
- Alabama (4)
- Idaho (3)
- Wyoming (3)
- Iowa (3)
- Vermont (3)
- Kansas (3)
- Montana (2)
- Maine (2)
- Delaware (2)
- New Mexico (1)
- Mississippi (1)
- Alaska (1)